Literature DB >> 12221935

Elimination of Pasteurella pneumotropica from a contaminated mouse colony by oral administration of Enrofloxacin.

Yutaka Ueno1, Ritsuko Shimizu, Ryoko Nozu, Satoru Takahashi, Masayuki Yamamoto, Fumihiro Sugiyama, Akira Takakura, Toshio Itoh, Ken-ichi Yagami.   

Abstract

Enrofloxacin, a fluoroquinolone bactericidal antibiotic, was administered in an attempt to eradicate Pasteurella pneumotropica (P. pneumotropica) from a contaminated mouse colony. Contaminated mice, maintained within 4 animal rooms, were administered Enrofloxacin in drinking water at a daily dosage of 25.5 mg/kg for 2 weeks. Following one week of Enrofloxacin treatment, mice were selected randomly from each room and examined for P. pneumotropica. This procedure was repeated two or three times until all mice examined tested negative for the Pasteurella strain. With the exception of one room, treated mice consistently tested negative for P. pneumotropica for up to 45 weeks following completion of Enrofloxacin treatment. Thus, oral administration of Enrofloxacin significantly eliminated P. pneumotropica from a contaminated mouse colony.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221935     DOI: 10.1538/expanim.51.401

Source DB:  PubMed          Journal:  Exp Anim        ISSN: 0007-5124


  5 in total

1.  Elimination of Pasteurella pneumotropica from a mouse barrier facility by using a modified enrofloxacin treatment regimen.

Authors:  Justin W Towne; April M Wagner; Kurt J Griffin; Adam S Buntzman; Jeffrey A Frelinger; David G Besselsen
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

2.  Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica.

Authors:  Calvin C Patten; Matthew H Myles; Craig L Franklin; Robert S Livingston
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

3.  Molecular and virulence characteristics of an outer membrane-associated RTX exoprotein in Pasteurella pneumotropica.

Authors:  Hiraku Sasaki; Hiroki Ishikawa; Toru Sato; Satoshi Sekiguchi; Hiromi Amao; Eiichi Kawamoto; Tetsuya Matsumoto; Kazuhiko Shirama
Journal:  BMC Microbiol       Date:  2011-03-17       Impact factor: 3.605

4.  Efficacy of enrofloxacin in a mouse model of sepsis.

Authors:  Andrea R Slate; Sheila Bandyopadhyay; Kevin P Francis; Mark G Papich; Brian Karolewski; Eldad A Hod; Kevin A Prestia
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

5.  Characterization of Biofilm Formation in [Pasteurella] pneumotropica and [Actinobacillus] muris Isolates of Mouse Origin.

Authors:  Martin Sager; W Peter M Benten; Eva Engelhardt; Christina Gougoula; Laurentiu Benga
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.